A W Lees, G W Allan, J Smith, W F Tyrell, R J Fallon. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh： See more » Bilirubin/bloodDrug Eruptions/etiologyDrug Hypersensitivity/etiologyEthambutol/administration & dosageEthambutol/therapeutic useHumansIsoniazid/administration & dosageIsoniazid/therapeutic useMycobacterium tuberculosis/isolation & purificationRecurrenceRifampin/administration & dosageRifampin/adverse effectsRifampin/therapeutic useSputum/microbiologyTransaminases/bloodTuberculosis, Pulmonary/drug therapyTuberculosis, Pulmonary/microbiologyTuberculosis, Pulmonary/pathology
Substances： See more » EthambutolTransaminasesBilirubinIsoniazidRifampin
Year: 1972 PMID： 4260668 DOI： 10.1016/s0012-3692(15)39159-5
Source DB: PubMed Journal: Chest ISSN： 0012-3692 Impact factor: 9.410